2-ME is a metabolite of 17ß-estradiol that displayed anti-proliferative properties in various cancers, although it’s mechanisms of action that may be independent of ER remain unclear, involving disruption of microtubules, blockade of angiogenesis and induction of apoptosis (25, 26). Here, ESR1 is linked to cancer.